Allelica offers state-of-the-art tools designed to integrate genetics into clinical practice to reduce the burden of common disease. We enable physicians to provide cutting-edge personalized risk assessments across a range of conditions. The Allelica platform enhances traditional care with comprehensive genetic insights, allowing for more precise, evidence-based interventions.
In this webinar, Dr. Douglas Jacoby, Medical Director of the Penn Medicine Center for Preventive Cardiology and Lipid Management, discusses his experience prescribing PRS testing for patients and how he uses results to improve clinical management.
“PRS has become a ‘tie-breaker’ for clinical decision-making in patients with uncertain risk profiles, giving us confidence we need to make the most effective treatment decisions.”
Dr. Jeffrey Anderson,
Intermountain Medical Center
“PRS testing helps guide decisions in uncertain cases, brings clarity to patients with unexplained events, and facilitates more personalized, thoughtful discussions about risk.”
Dr. Justin Fox,
Hamilton Cardiology Associates
Discover how leading providers like Dr. Rigved Tadwalkar of the Pacific Heart Institute are using Allelica’s PRS test to proactively prevent heart attacks.
Allelica’s advanced PRS technology equips physicians with the tools needed to advance precision medicine. By incorporating genetic risk scores into routine practice, you can identify high-risk patients across multiple disease categories, tailor interventions more effectively, and lead the way in personalized healthcare.
Allelica’s bioinformatics platform empowers clinical laboratories to bring multi-ancestry PRS and advanced genomic testing in-house with confidence. Available as both cloud-based and on-premise solutions when data cannot leave the building. Allelica software is designed for seamless integration into your existing workflows. With customizable panels and multilingual, white-label reporting, Allelica provides the flexibility and scalability needed to meet your lab’s specific needs while maintaining the highest standards of security and performance. Elevate your lab's capabilities with Allelica’s advanced, adaptable tools.
Allelica’s multi-ancestry PRS trial stratification platform helps pharmaceutical and biotech companies shorten trial timelines, reduce participant numbers, and test more programs within the same budget. By integrating cutting-edge genetics and AI-driven analytics, we identify the right patients for each study, increasing statistical power and maximizing the likelihood of success. Our approach also enables companies to salvage underperforming or failed trials by uncovering subpopulations of patients who benefit most from a given therapy, turning potential setbacks into actionable insights. From trial design to execution, our comprehensive tools and expertise ensure your clinical programs are faster, leaner, and more cost-effective, accelerating the path to market for transformative therapies.
CLIA registration number: 22D2315916
Our products are developed and validated using world class datasets and state-of-the-art technology to ensure the highest level of quality.
We are a group of international scientists and researchers committed to maintaining standards of academic excellence every step of the way.
Everything we do works towards our common goal of providing tangible improvement in preventive healthcare to help humans live a longer, healthier life.